Hearing Loss Trial, Recruiting NCT06174038 Sponsor: Columbia University Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT06174038
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 55 and 75 years old
  • People with mild to moderate hearing loss that developed in adulthood, based on a standard hearing test result in their better ear
  • People whose hearing loss is at a level where hearing aids could help, shown by being able to correctly repeat at least 60% of words in a quiet environment (in the better ear)
  • People with a type of mild memory impairment (called amnestic mild cognitive impairment), confirmed through specific memory and thinking tests with scores falling within defined ranges
  • People who have a family member, friend, or carer available to assist with certain memory and daily living assessments during the study
  • People who live in the community (not in a care facility)
  • People who are fluent in English or Spanish
  • People who are able to remain available in the local area for the full duration of the study

Who may not be able to join:

  • People with hearing loss that was present from birth, is linked to a known genetic cause, or began before middle age (before age 45)
  • People who have already been diagnosed with dementia
  • People who have difficulty carrying out two or more basic daily activities (such as dressing or bathing)
  • People who currently use or have regularly used hearing aids in the past 6 months (beyond very brief trials)
  • People who are not willing to wear hearing aids for at least 8 hours per day
  • People who have a medical condition that makes hearing aid use unsafe (for example, an actively draining ear)
  • People with vision problems that remain significant even with glasses or contact lenses, based on a specific vision chart test
  • People with a type of hearing loss caused by a blockage or structural problem in the ear that cannot be treated, where the gap between two types of hearing test measurements is above a certain level across multiple sound frequencies in both ears (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Justin S Golub, MD, Columbia University

Phone: 646-317-3252

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2024
Est. completion
31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Free and Cued Selective Reminding Test (FC-SRT) Score; Delayed Recall Log Memory IIa, (DRLM) Score; Digit Symbol Substitution Test, (DSST) Score; Mini-Mental State Examination 2, (MMSE-2) Score; Trail Making Test Part B, (TMTB) Score; Activities of Daily Living for Mild Cognitive Impairment, (ADCS-ADLPI) Score; Social Activity Frequency; Ability to Participate in Social Roles and Activities (APSR) Score; Community Integration Measure (CIM) Score; Cohens Social Network Index (SNI) Score; University of California Loneliness Scale (ULS) Score; Brain MRI Measures

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov